Wednesday, April 20th at 2 PM ET
After a very long road, industry is now fast approaching the required submission deadline, December 28, 2022, for Risk Evaluation and Mitigation Strategy (REMS) in Structured Product Labeling (SPL) format. While participation is currently voluntary, and has been since September 2016, compliance with this guidance will be required as per the final guidance issued December 2020.
In this webinar, Reed Tech subject-matter experts, Gary Saner and David Wilson, discussed the structured format requirements for REMS to help regulatory experts understand what the final guidance includes, what actions are required of you and the deadlines surrounding these activities. The speakers help explain how this move to structured content will increase access and ease of use for all REMS content stakeholders including sponsors, FDA, Providers, prescribers and patients.
Key Topics
Register now to view the recording for the webinar and to download the slide deck!
LexisNexis Reed Tech is the provider of best-in-class information-based solutions and services to meet the needs of the life sciences industry, government agencies, and the intellectual property market. Our customers are located throughout the world and include a wide range of medical device manufacturers and pharmaceutical companies, the U.S. government, numerous Patent Authorities, and IP-driven companies and law firms. The corporate mission is to advance humanity by delivering better outcomes to the innovation community. Reed Tech is a LexisNexis company.
Life Sciences Solutions Driven by Accuracy and Insight
Reed Tech offers product and service solutions to help Life Sciences professionals gain control over their own and their industry's data. Our offerings smooth the collection, transformation, submission and analysis of regulatory data for manufacturers and distributors of medical device and drug products, and for those who support them in consulting and IT roles.
7 Walnut Grove Drive
Horsham, PA 19044
+1-215-557-3010
Would you like to learn more about how Reed Tech can streamline your medical device and pharma submissions? Speak to one of our experts!
Copyright © 2024 LexisNexis ReedTech. All Rights Reserved.